433 related articles for article (PubMed ID: 26046559)
21. The Role of Environment and Lifestyle in Determining the Risk of Multiple Sclerosis.
Hedström AK; Olsson T; Alfredsson L
Curr Top Behav Neurosci; 2015; 26():87-104. PubMed ID: 25707369
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
Salzer J; Nyström M; Hallmans G; Stenlund H; Wadell G; Sundström P
Mult Scler; 2013 Oct; 19(12):1587-91. PubMed ID: 23549431
[TBL] [Abstract][Full Text] [Related]
23. Environmental factors and their regulation of immunity in multiple sclerosis.
Koch MW; Metz LM; Agrawal SM; Yong VW
J Neurol Sci; 2013 Jan; 324(1-2):10-6. PubMed ID: 23154080
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D and multiple sclerosis: an update.
Cantorna MT
Nutr Rev; 2008 Oct; 66(10 Suppl 2):S135-8. PubMed ID: 18844840
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology of multiple sclerosis.
Ramagopalan SV; Sadovnick AD
Neurol Clin; 2011 May; 29(2):207-17. PubMed ID: 21439437
[TBL] [Abstract][Full Text] [Related]
26. Environmental and genetic factors in pediatric inflammatory demyelinating diseases.
Waubant E; Ponsonby AL; Pugliatti M; Hanwell H; Mowry EM; Hintzen RQ
Neurology; 2016 Aug; 87(9 Suppl 2):S20-7. PubMed ID: 27572857
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D in autoimmune liver disease.
Smyk DS; Orfanidou T; Invernizzi P; Bogdanos DP; Lenzi M
Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):535-45. PubMed ID: 23845396
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update.
Ascherio A; Munger KL
Semin Neurol; 2016 Apr; 36(2):103-14. PubMed ID: 27116717
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D: a candidate for the environmental effect in multiple sclerosis - observations from Norway.
Kampman MT; Brustad M
Neuroepidemiology; 2008; 30(3):140-6. PubMed ID: 18382112
[TBL] [Abstract][Full Text] [Related]
30. Environmental factors and their interactions with risk genotypes in MS susceptibility.
Hedström AK; Alfredsson L; Olsson T
Curr Opin Neurol; 2016 Jun; 29(3):293-8. PubMed ID: 27035899
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D: a link between Epstein-Barr virus and multiple sclerosis development?
Disanto G; Meier U; Giovannoni G; Ramagopalan SV
Expert Rev Neurother; 2011 Sep; 11(9):1221-4. PubMed ID: 21864064
[No Abstract] [Full Text] [Related]
32. Impact of the environment on multiple sclerosis.
Løken-Amsrud KI; Lossius A; Torkildsen Ø; Holmøy T
Tidsskr Nor Laegeforen; 2015 May; 135(9):856-60. PubMed ID: 25991624
[TBL] [Abstract][Full Text] [Related]
33. Multiple sclerosis: geoepidemiology, genetics and the environment.
Milo R; Kahana E
Autoimmun Rev; 2010 Mar; 9(5):A387-94. PubMed ID: 19932200
[TBL] [Abstract][Full Text] [Related]
34. Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?
Pierrot-Deseilligny C; Souberbielle JC
Brain; 2010 Jul; 133(Pt 7):1869-88. PubMed ID: 20584945
[TBL] [Abstract][Full Text] [Related]
35. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
Banwell B; Bar-Or A; Arnold DL; Sadovnick D; Narayanan S; McGowan M; O'Mahony J; Magalhaes S; Hanwell H; Vieth R; Tellier R; Vincent T; Disanto G; Ebers G; Wambera K; Connolly MB; Yager J; Mah JK; Booth F; Sebire G; Callen D; Meaney B; Dilenge ME; Lortie A; Pohl D; Doja A; Venketaswaran S; Levin S; Macdonald EA; Meek D; Wood E; Lowry N; Buckley D; Yim C; Awuku M; Cooper P; Grand'maison F; Baird JB; Bhan V; Marrie RA
Lancet Neurol; 2011 May; 10(5):436-45. PubMed ID: 21459044
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection.
Hedström AK
Front Immunol; 2023; 14():1212676. PubMed ID: 37554326
[TBL] [Abstract][Full Text] [Related]
37. Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection.
Pender MP
Autoimmun Rev; 2009 Jun; 8(7):563-8. PubMed ID: 19254880
[TBL] [Abstract][Full Text] [Related]
38. Targeting Epstein-Barr virus infection as an intervention against multiple sclerosis.
Jons D; Sundström P; Andersen O
Acta Neurol Scand; 2015 Feb; 131(2):69-79. PubMed ID: 25208981
[TBL] [Abstract][Full Text] [Related]
39. EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.
Nejati A; Shoja Z; Shahmahmoodi S; Tafakhori A; Mollaei-Kandelous Y; Rezaei F; Hamid KM; Mirshafiey A; Doosti R; Sahraian MA; Mahmoudi M; Shokri F; Emery V; Marashi SM
Med Microbiol Immunol; 2016 Apr; 205(2):143-54. PubMed ID: 26365612
[TBL] [Abstract][Full Text] [Related]
40. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
Otto C; Hofmann J; Ruprecht K
Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
